School of Medicine


Showing 211-220 of 242 Results

  • Janey S.A. Pratt, MD

    Janey S.A. Pratt, MD

    Clinical Professor, Surgery - Pediatric Surgery

    BioDr. Janey S.A. Pratt, MD, FACS, FASMBS is a general surgeon who specializes in Laparoscopic and Robotic General and Metabolic and Bariatric Surgery (MBS). She began her career in general surgery at Massachusetts General Hospital, where she was a founding member of the MGH Weight Center. As surgical director she introduced minimally invasive MBS and adolescent MBS to MGH in 2001 and 2007 respectively. In 2011 Dr. Pratt took over as Director at the MGH Weight Center and continued to work on several national committees towards improving access and care for adolescents with severe obesity. Dr. Pratt continued to practice general surgery throughout her tenure at MGH seeing patients with breast cancer, hernias, and obesity. She performed advance minimally invasive surgery (MIS) as well as advanced endoscopy.

    In 2016 Dr. Pratt moved to California where she began her work at Stanford University, splitting her time between the Lucille Packard Children’s Hospital and the Palo Alto VA. She performs Minimally Invasive MBS as well as endoscopy. Dr. Pratt has trained in robotic surgery as well. As a Clinical Professor of Surgery, Dr. Pratt is involved in training Stanford medical students and residents both in the OR, in clinic, in simulation labs and in the classroom. Dr. Pratt is the Director of the Adolescent Metabolic and Bariatric Surgery Program at Lucille Packard Children's Hospital. This is an MBSAQIP accredited program in a free-standing children's hospital dedicated to the multidisciplinary care of children with obesity. This program is one of the top 5 programs in the country. Dr. Pratt has been involved in creating and updated guidelines for Adolescent MBS since 2005. In 2018 she was first author on the ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines. Her research interests include MIS MBS, pediatric obesity treatment and the use of medications to improve outcomes of MBS. Dr. Pratt frequently lectures on the subject of Adolescent Metabolic and Bariatric Surgery.

  • Guillem Pratx

    Guillem Pratx

    Associate Professor of Radiation Oncology (Radiation Physics)

    Current Research and Scholarly InterestsThe Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.

  • Carl Preiksaitis

    Carl Preiksaitis

    Clinical Instructor, Emergency Medicine

    BioDr. Carl Preiksaitis is a Medical Education Fellow and Clinical Instructor in the Department of Emergency Medicine at Stanford University. Dr. Preiksaitis completed his medical training at New York University School of Medicine and a residency in emergency medicine at Stanford. His scholarly interests include digital media and medical education, reproductive healthcare in the emergency department, and heath-care innovation. He is currently pursuing a master's degree in medical education at the University of Cincinnati.

  • Allison Pribnow

    Allison Pribnow

    Clinical Assistant Professor, Pediatrics - Hematology & Oncology

    Current Research and Scholarly InterestsSolid Tumors, Bone Sarcomas, Global Oncology, Health Disparities

  • James Priest

    James Priest

    Adjunct Clinical Assistant Professor, Pediatrics - Cardiology

    Current Research and Scholarly InterestsThe Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.

  • David Prince

    David Prince

    Edward F. and Irene Thiele Pimley Professor of Neurology and the Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsExperiments examine
    1)intrinsic properties of neuronal membranes; actions of neurotransmitters that regulate neocortical and thalamic excitability
    2) chronic epileptogenesis following cortical injury; changes in intracortical connectivity and receptors;
    3) effects of early injury and activity on cortical development/maldevelopment Electrophysiological, anatomical and pharmacological techniques employed.
    4. prophylaxis of postraumatic epilepsy
    5. Neocortical interneuronal function/modulation

  • Lance Prince

    Lance Prince

    Philip Sunshine, MD, Professor of Neonatology

    BioLawrence (Lance) S. Prince, MD, PhD, is the Division Chief for Neonatal and Developmental Medicine at Stanford School of Medicine. Dr. Prince was previously a Professor of Pediatrics and Chief of the Division of Neonatology at the University of California, San Diego and Rady Children’s Hospital, San Diego.

    Dr. Prince has a long and distinguished career mentoring clinical and scientific trainees and students, many of whom have gone on to establish their own successful careers as academic physician investigators. As a physician scientist, Dr. Prince leads a basic science laboratory focusing on the mechanisms regulating developmental immunology and lung injury and repair. Dr. Prince received a Bachelor of Science in Chemistry from University of Miami, an MD/PhD with a focus in Cell Biology from University of Alabama at Birmingham, and postdoctoral fellowship, Pediatrics residency, and Neonatal-Perinatal Medicine Fellowship training at the University of Iowa. Before arriving in California, Dr. Prince was an Associate Professor of Pediatrics at Vanderbilt University.

    Dr. Prince’s research interests include the molecular and cellular mechanisms controlling lung development and the maturation of the fetal and neonatal immune systems. He has a particular clinical interest in managing and treating neonatal lung diseases, especially bronchopulmonary dysplasia (BPD) in babies born extremely preterm. Dr. Prince’s research team focuses primarily on the development of innate immunity during fetal life as it impacts health and disease in preterm infants. The laboratory is investigating how microbes including Group B streptococcus exploit the unique features of neonatal macrophages to avoid immune detection and cause disease, as well as leading a number of clinical and translational investigations.